Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-490-3 | CAS number: 96-22-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: no GLP compliance, pre-guideline study
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Mutgenicity studies on ketone solvents: methyl ethyl ketone, methyl isobutyl ketone, and isophorone
- Author:
- O'Donoghue JL et al.
- Year:
- 1 988
- Bibliographic source:
- Mutation Research 206, 149-161
- Reference Type:
- study report
- Title:
- Unnamed
- Report date:
- 1984
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- no
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Butanone
- EC Number:
- 201-159-0
- EC Name:
- Butanone
- Cas Number:
- 78-93-3
- Molecular formula:
- C4H8O
- IUPAC Name:
- butan-2-one
- Details on test material:
- - Name of test material (as cited in study report): MEK
- supplied froim Celanese Corporation
- Analytical purity: 99.9 %
- test material was blanketed with nitrogen and stored at room temperature
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Labs, Inc Kingston, N.Y.
- Age at study initiation: 6-8 weeks
- Weight at study initiation: males: 28-37 g, females: 22-26 g
- Assigned to test groups randomly: yes
- Housing: mice were-housed up to six per cage in plastic autoclavable cages with wire lids
- Diet (e.g. ad libitum): free access to a certified laboratory rodent chow which had been analyzed for environmental
contaminants
- Water (ad libitum): yes
- Acclimation period: quarantined for 10-14 days after receipt
ENVIRONMENTAL CONDITIONS
- Temperature: 74 °F
- Humidity: 50+-20 %
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle solvent used: corn oil
- Amount of vehicle (if gavage or dermal): 10 mL of test item-corn oil mix / kg bw - Details on exposure:
- - for the micronucleus assay, male and female mice were dosed by a single i.p. injection of MEK in corn oil at a dose level of 1.96 mL/kg.
- Duration of treatment / exposure:
- - animals were sacrficed 12, 24 or 48 hours after single dose exposure
- Frequency of treatment:
- - animals were given a single dose
- Post exposure period:
- - 12, 24 or 48 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1.96 mL/kg bw
Basis:
other: nominal dose given intraperitoneally
- No. of animals per sex per dose:
- - 5 per sex and time point of termination
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - TEM (Triethylene melanime)
- Route of administration: intraperitoneal
- Concentration: 0.25 mg/kg bw
Examinations
- Tissues and cell types examined:
- - Bone marrow blood cells were prepared and polychromatic and normochromatic erythrocytes examined
- Details of tissue and slide preparation:
- DETAILS OF SLIDE PREPARATION:
- the femur was exposed and bone marrow aspirated into a syringe containing fetal calf serum
- cells were washed, centrifuged, resuspended and smears prepared
- May-Gruenwald-Giemsa stain was used to stain the bone marrow preparations
- 1000 polychromatic erythrocytes were scored on coded slides for the presence of micronuclei
- Micronucleated normocytes were also counted - Evaluation criteria:
- The ratio of normochromatic to polychromatic erythrocytes is presented for each animal and treatment group as the proportion of polychromatic erythrocytes per total erythrocytes. The incidence of micronuleated polychromatic erythrocytes per 1000 polychromatic erythrocytes is presented for each animal and treatment group. An analysis of variance was used to compare the incidence of micronucleated polychromatic erythrocytes of the treatment group and solvent control groups.
The test article is considered to induce a positive response if :
treatment-related increase (p<0.05, one-way ANOVA, Duncan's multiple range test) in micronucleated polychromatic erythrocytes is observed relative to the vehicle control. All data, inclucling reproducibility, was evaluated and a final judgment made on scientific basis. - Statistics:
- - an one-way analysis of variance and Duncan's multiple range test (P =< 0.05) was used to assess the statistical significance of any observed effects
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- not specified
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
For the acute dose-finding study, MEK was administered by i.p. injection to male and female CD-I mice at 12 dose levels: 8.0, 6.0,4.0, 3.2, 3.0,2.8, 2.6, 2.4, 2.2, 2.0, 1.0 and 0 mL/kg body weight which was administered in a total volume of 10 ml test article-vehicle mixture/kg body weight.
Using a probit analysis, the LD20 for males and females combined was calculated as 1.91 +- 0.2 mL test article/kg.
RESULTS OF DEFINITIVE STUDY
There were no significant differences in the ratio of polychromatic erythrocytes to normochromatic erythrocytes between treatment groups regardless of treatment or sacrifice time when analyzed by sex (p>0.05, ANOVA).
The number of micronucleated polychromatic erythrocytes per 1000 PCE was increased above the vehicle control 24 hours after administration of MEK, however the increase appears to be due to a low background and was not statistically significant when compared to all treatment and vehicle control groups of the same sex regardiess of sacrifice time (p>0.05, ANOVA) or when compared alone to all three vehicle controls of the same sex.
TEM induced a significant increase in micronucleated PCE in male and female mice (p<0.01, Student's t test).
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
- Executive summary:
In a CD-1 mouse bone marrow micronucleus assay 5 animals/sex were treated by a single intraperitoneal injection with MEK (99.9 % a.i.) at a doses of 0 or 1.96 mL/kg bw MEK in corn oil. This dose was selected as the maximum tolerated dose (LD20 ) based upon a preliminary toxicity study. Bone marrow cells were harvested at 12, 24 or 48 hours post-treatment, stained and scored for the presence of micronucei.
There was no significant increase in the frequency of micronucleated polychromatic erythrocytes in bone marrow in males or female mice.
The positive control (TME) induced the appropriate response.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.